NO-cGMP pathway has a controversial role in neuroinflammation/demyelinating models.
Wild type and iNOS−/− mice treated with sildenafil or untreated were used.
Sildenafil reduced ICAM, VCAM, PKG, sGC in wild type mice.
The iNOS−/− mice had reduced VCAM, ICAM, GFAP, PKG and sGC, and damaged myelin.
In iNOS−/−, sildenafil had no anti-inflammatory effect, but improved myelin.